Clinical Trials in Pittsburgh

Showing 9761-9780 of 21,047 trials

Targeted Intervention for Insufficient Sleep Among Typically-Developing Adolescents

NCT04163003

The overall aim of Dr. Levenson's research proposal is to test the acceptability, feasibility, and preliminary outcomes of a sleep promotion program delivered to 13-15 year olds who report insufficient sleep. Dr. Levenson will examine the feasibility and acceptability of the program through a randomized pilot trial (n=40) that uses a two-period, wait-list control design. Then, Dr. Levenson will test whether the program is associated with changes in sleep, motivation, and four outcome domains: academic functioning, attention, risk behavior, and affect. Such a broadly relevant program has the potential for enormous public health impact by improving sleep and facilitating healthy development across a range of domains among typically-developing adolescents who are highly vulnerable to adverse consequences.

Sleep Disturbance

University of Pittsburgh82 participantsStarted Oct 2019

Pittsburgh, Pennsylvania, United States

COMPLETED< 1 mile

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

NCT00778206

The objective of this study is to evaluate the safety of long-term treatment with Kuvan.

PhenylketonuriaHyperphenylalaninaemia

BioMarin Pharmaceutical1,887 participantsStarted Sep 2008

Los Angeles, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +42 more locations

Targeted Intervention for Insufficient Sleep Among Typically-Developing Adolescents

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Find Trials by Condition in Pittsburgh

Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke

Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)

A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)

Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention

A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.

Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma

Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer

A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab

A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.

Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine Tumour

Critical Health Assessment and Outcomes Score/Study

Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma

A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma

Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer

Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise

NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine

Clot Dissolving Treatment for Blood Clots in the Lungs

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced Solid Tumors